Skip to main content
Clinical Trials/ACTRN12605000296639
ACTRN12605000296639CompletedPhase 2

Randomised placebo controlled study on the safety and efficacy of a herbal tonic for cessation of smoking - five week pilot study

CigArrest Pty ltd0 sites60 target enrollmentStarted: September 5, 2005Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
25 Years to 75 Years (—)
Sex
All

Inclusion Criteria

  • 1) 3 or more years as a smoker 2) Smoke greater than or equal to 20 cigarettes per day 3) Fagerstrom greater than or equal to 5 4) Exhaled carbon monoxide concentration greater than or equal to 10ppm 5) In good general health.

Exclusion Criteria

  • 1) Pregnant or lactating females or women likely to become prgnant during the study2) History of serious or unstable cardiac, renal, hypertensive, pulmonary, endocrine, neurologic or neuropsychiatric disorders 3) History of alcohol or substance abuse4) Regular use of any non-cigarette tobacco products5) Current use of other smoking cessation treatments6) Use of any complementary medicine smoking cessation products in the previous 6 months7) Clinically abnormal liver function at baseline8) Unwilling to comply with study protocol9) Subjects who have participated in another clinical trial in the last 30 days10) Any other condition which in the opinion of the investigators could compromise the study.

Investigators

Sponsor
CigArrest Pty ltd

Similar Trials

Randomised placebo controlled study on the... | Clinical Trial